Adjuvant Radiotherapy and/or Chemotherapy for Endometrial Cancer, Status as at 2019: Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO)

The role of adjuvant radiotherapy and/or chemotherapy in the primary treatment of endometrial cancer with a high risk of recurrence has still not been conclusively determined. The results of 3 large randomized controlled studies on different aspects of this issue have been published in full in recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Emons, Günter, Tempfer, Clemens, Battista, Marco Johannes, Mustea, Alexander, Vordermark, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924345/
https://www.ncbi.nlm.nih.gov/pubmed/31875857
http://dx.doi.org/10.1055/a-1019-7720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924345/
https://www.ncbi.nlm.nih.gov/pubmed/31875857
http://dx.doi.org/10.1055/a-1019-7720

Ejemplares similares